位置:首页 > 产品库 > PPT
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
PPT
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
PPT图片
CAS NO:263717-53-9
规格:98%
分子量:386.45
包装与价格:
包装价格(元)
1mg询价
5mg询价
10mg询价
25mg询价

ERα agonist
CAS:263717-53-9
分子式:C24H22N2O3
分子量:386.45
纯度:98%
存储:Store at -20°C

Background:

Estrogen receptor α (ERα) and ERβ are ligand-activated transcription factors that mediate the actions of estrogen. Activation of ERα, but not ERβ, is required for the cardioprotective effects of estradiol. Propylpyrazole triol (PPT) is an ERα selective agonist with a 410-fold relative binding affinity for ERα (49%) versus ERβ (0.12%) and therefore activates gene transcription only through ERα.[1],[2] In an in vivo rabbit model of ischemia-reperfusion injury, treatment with estradiol and PPT, but not diarylpropinitrile (a selective agonist of ERβ) significantly decreased the infarct size compared with vehicle.[3]
Reference:
[1]. Stauffer, S.R., Coletta, C.J., Tedesco, R., et al. Pyrazole ligands: Structure-affinity/activity relationships and estrogen receptor-α-selective agonists. Journal of Medicinal Chemistry 43, 4934-4947 (2000).
[2]. Meyers, M.J., Sun, J., Carlson, K.E., et al. Estrogen receptors-β potency-selective ligands: Structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogus. Journal of Medicinal Chemistry 44, 4230-4251 (2001).
[3]. Booth, E.A., Obeid, N.R., and Lucchesi, B.R. Activation of estrogen receptor-α protects the in vivo rabbit heart from ischemia-reperfusion injury. American Journal of Physiology 289, H2039-H2047 (2005).


 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024